Showing results (71-80 of 122) with videos related to
Sort By:
Pageof 13
Journal of Clinical Medicine|October 14, 2023
The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII ConcentrateTakeshi Matsumoto, Hideo Wada, Katsuya Shiraki, et al.Journal of Vascular Surgery|July 22, 2008
Basic fibroblast growth factor slow release stent graft for endovascular aortic aneurysm repair: a canine model experimentMasaki Kajimoto, Takatsugu Shimono, Koji Hirano, et al.Cardiovascular Research|January 25, 2005
Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in miceKiyohito Yamamoto, Koji Onoda, Yasuhiro Sawada, et al.Artificial Organs|May 10, 2002
Long-term results of valve replacement with the CarboMedics prosthetic heart valveKoji Onoda, Tomoaki Suzuki, Naoki Kanemitsu, et al.The Journal of Thoracic and Cardiovascular Surgery|August 21, 2003
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulationShinji Kanemitsu, Masakatsu Nishikawa, Koji Onoda, et al.Journal of Clinical Medicine|April 13, 2023
Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic DiseasesMinoru Ezaki, Hideo Wada, Yuhuko Ichikawa, et al.Circulation|May 20, 2009
In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound studyYoshihide Mitani, Hiroyuki Ohashi, Hirofumi Sawada, et al.Journal of Clinical Medicine|November 13, 2025
Diagnostic and Prognostic Evaluation of Disseminated Intravascular Coagulation Using the Disseminated Intravascular Coagulation IndexEri Nakano, Hideo Wada, Akitaka Yamamoto, et al.The Journal of Thoracic and Cardiovascular Surgery|September 9, 2004
Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery graftsKazuya Fujinaga, Koji Onoda, Kiyohito Yamamoto, et al.Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenaseKentarou Inoue, Motoshi Takao, Fumiaki Watanabe, et al.Pageof 13